Company intelligence / Profile preview

Asclepius Meditec

Ownership: Private
Employees: ~451
Development stage: Other

Overview

Asclepius Meditec has developed medical-grade hydrogen/oxygen ventilators and nebulizers that have been clinically studied in nearly 200 basic studies, 18 single-center clinical studies, 6 multi-center clinical studies, including applications in COVID‑19 patients where improvements were observed in respiratory symptoms. The company has published over 70 SCI papers and holds more than 300 patents globally.

Therapeutic areas: OncologyPulmonologyInfectious DiseasesNeurology
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Collaborated with international organizations to provide emergency support during the COVID‑19 pandemicDonated equipment to Nepalese NGOs during crisis response

Beyond the preview

Go deeper on Asclepius Meditec.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Asclepius Meditec.